Company Analysis ResMed Inc.
1. Summary
Advantages
- Price (17.7 $) is less than fair price (34.28 $)
- Dividends (1.82%) are higher than the sector average (1.72%).
- The stock's return over the last year (41.11%) is higher than the sector average (-35.53%).
- The company's current efficiency (ROE=22.7%) is higher than the sector average (ROE=13.19%)
Disadvantages
- Current debt level 12.72% has increased over 5 years from 0.2919%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
ResMed Inc. | Healthcare | Index | |
---|---|---|---|
7 days | 0% | -0.4% | 2.8% |
90 days | 29.4% | -37.9% | 2.7% |
1 year | 41.1% | -35.5% | 26% |
RSMDF vs Sector: ResMed Inc. has outperformed the "Healthcare" sector by 76.64% over the past year.
RSMDF vs Market: ResMed Inc. has outperformed the market by 15.12% over the past year.
Stable price: RSMDF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: RSMDF with weekly volatility of 0.7907% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (17.7 $) is lower than the fair price (34.28 $).
Price significantly below the fair price: The current price (17.7 $) is 93.7% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (2.56) is lower than that of the sector as a whole (31.5).
P/E vs Market: The company's P/E (2.56) is lower than that of the market as a whole (46.99).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.5369) is lower than that of the sector as a whole (3.36).
P/BV vs Market: The company's P/BV (0.5369) is higher than that of the market as a whole (-8.99).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.5574) is lower than that of the sector as a whole (3.24).
P/S vs Market: The company's P/S indicator (0.5574) is lower than that of the market as a whole (4.88).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (2.03) is lower than that of the sector as a whole (9.95).
EV/Ebitda vs Market: The company's EV/Ebitda (2.03) is lower than that of the market as a whole (25.22).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 12.83% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (12.83%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-52.93%).
5.4. ROE
ROE vs Sector: The company's ROE (22.7%) is higher than that of the sector as a whole (13.19%).
ROE vs Market: The company's ROE (22.7%) is higher than that of the market as a whole (-8.21%).
5.5. ROA
ROA vs Sector: The company's ROA (14.99%) is higher than that of the sector as a whole (6.14%).
ROA vs Market: The company's ROA (14.99%) is higher than that of the market as a whole (4.86%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (21.1%) is higher than that of the sector as a whole (15.56%).
ROIC vs Market: The company's ROIC (21.1%) is higher than that of the market as a whole (11.03%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 1.82% is higher than the average for the sector '1.72%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 1.82% has been steadily paid over the past 7 years, DSI=1.
Weak dividend growth: The company's dividend yield 1.82% has been growing weakly or stagnant over the past 5 years. Growth over only 4 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (27.65%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription